The agency argues that reverse-payment agreements ... company paying compensation to the generic in exchange for the generic's agreement to stop contesting the patent and stay out of the market." ...

or a generic drug manufacturer from Feb. 1, 2018, until the class certification order. In exchange for the settlement payment, the plaintiff class will dismiss its legal action against Gilead and its ...

The plaintiffs allege the accord was an unlawful “reverse payment agreement" that delayed Hikma from marketing generic Xyrem for years. Hikma’s generic entered the market last year.

New Delhi, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The global generic pharmaceuticals contract manufacturing market is anticipated to be worth US$ 135.43 billion by 2033, growing at a CAGR of 6.15% during ...

Sunshine Biopharma (SBFM) announced that is has signed a strategic agreement granting it the rights to market two new generic antibiotics in Canada. The Company anticipates launching these new ...

Inflation can benefit payments companies generally because they take a small slice of every transaction. So in theory their take should rise along with the general price level. But if inflation is ...

As part of the agreement, Royalty acquired an interest in Ionis’ Spinraza royalty for an upfront payment of $500 million and an interest in pelacarsen for up to $625 million. Spinraza is a treatment ...

Collegium Pharmaceuticals has entered into an authorized generic agreement with Hikma, in which Hikma will have the exclusive right to sell the authorized generic versions of Nucynta and Nucynta ...

The new FDA-funded collaboration builds on research performed by EpiVax during two previous FDA contracts that evaluated the immunogenicity risk of generic drug impurities. Under the first ...

It is called the IRS Payment Agreement and there is a way to determine whether you are eligible for this plan or not. Everybody has a specific tax situation that will help them determine if they ...

Shohei Ohtani's massive, record-setting contract is going to have a lot of deferred payment. The superstar will eventually get that $700 million, but it won't all come within the next decade.